Stroke
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - *18 years; - Minimal passive range of motion (PROM) in shoulder joint: 0-80° abduction, 0-45° anterior flexion. - At least some volitional control of elbow flexion and extension; - Having given written informed consent prior to undertaking any study-related procedures.;In addition, the following inclusion criteria apply for stroke patients: - Patients need to have an unilateral upper extremity impairment; - Chronic (> 6 months) patients. In addition, the following inclusion criteria apply for adults with CP: - Adults with CP need to have an upper extremity impairment; - Spastic unilateral or spastic bilateral adults with CP.
Exclusion criteria
Exclusion criteria: - Inability to understand instructions (for example due to intellectual impairment); - History of pre-existing neuromusculoskeletal disorders that would influence the upper extremity function (e.g., presence of a prosthetics shoulder, other neurological condition which might affect upper extremity function, surgery/specific treatment * 6 months); - Damage skin of the arm that interferes with the measurement set-up and/or has negative influence for the participants; - Hemiplegic shoulder pain; - Patients with fixed contractures in the upper extremity that hinder the experimental setup. - Intellectual impairment, or psychiatric disorder that hinders understanding measurement instructions. ;In addition, the following exclusion criteria apply for adults with CP: Adults with very severe motor disorders: a level V on the gross motor function classification system (GMFCS) and/or a level V on the manual ability classification system (MACS).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameters are muscle weakness, spasticity, abnormal synergy and changed viscoelastic properties of the upper extremity, as measured with the Shoulder-Elbow Perturbation (SEP). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary study parameters are spasticity and abnormal synergy as measured with clinical assessment tools. Spasticity: In stroke patients and adults with CP: Tardieu scale. Synergy: In stroke patients: Brunnström Fugl-Meyer (BFM) of the upper extremity; In adults with CP: Test of Arm Selective Control (TASC). | — |
Countries
Netherlands
Outcome results
None listed